Viral Nucleocapsid
Viral Nucleocapsid - Related Videos
12:45
Preparation of Viral DNA from Nucleocapsids
0 Views •
Cited by 40 •
2011
We describe the process of isolating high purity herpesvirus nucleocapsid DNA from infected cells. The final DNA captured from solution is of high concentration and purity, making it ideally suited for high-throughput sequencing, high fidelity PCR reactions, and transfections to produce new viral recombinants.
02:36
In Vitro Reconstitution and Purification of Viral Nucleocapsid-Like Particles
0 Views •
2026
Source: Gao, Y., et al. Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus. J. Vis. Exp. (2021)The video demonstrates the in vitro assembly of virus-specific nucleocapsids from a purified RNA-free nucleoprotein–phosphoprotein complex, their purification by size exclusion chromatography, and validation of full-length viral RNA within the assembled particles.
08:33
Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
0 Views •
Cited by 8 •
2015
This protocol describes NAME, an assay that allows the rapid identification of molecules able to inhibit in vitro the chaperone activities of HIV-1 nucleocapsid protein.
09:08
Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
0 Views •
2021
For in-depth mechanistic analysis of the respiratory syncytial virus (RSV) RNA synthesis, we report a protocol of utilizing the chaperone phosphoprotein (P) for coexpression of the RNA-free nucleoprotein (N0) for subsequent in vitro assembly of the virus-specific nucleocapsids (NCs).
00:56
Viral Structure
0 Views •
2019
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid. Structural Classes of Viruses Many criteria are used to classify viruses, including capsid design. Most viruses...
FAQs
Specific interactions between viral RNA or DNA and nucleocapsid or capsid proteins organize the genome within the particle. Their arrangement can affect how efficiently the genetic material is packaged, protected, and later made available. Because these interactions coordinate several stages of the viral life cycle, changes in nucleocapsid structure may influence assembly, genome release, or replication.
The protein organization surrounding the genome can provide protection while the virus is assembled and present in an infectious particle. At an appropriate stage, that organization must also permit genome release or access for replication. This balance makes nucleocapsid structure biologically important: excessive stability could hinder release, whereas inadequate organization could compromise packaging or protection.
Nucleocapsid structure depends on whether the packaged genome is RNA or DNA and on the specific interactions formed with viral proteins. Comparing these arrangements can reveal differences in genome organization, particle assembly, and release. Such comparisons also help explain why nucleocapsid components may present different antigenic features, meaning immune systems can recognize related viral structures differently.
Researchers examine nucleocapsid components as targets of antibody and T-cell responses. These studies assess whether immune recognition is directed toward proteins associated with the packaged genome and whether recognition differs among viruses or viral structures. The resulting information can support analysis of antigenicity, the capacity to be recognized by the immune system, in infection and comparative virology.
Nucleocapsid components can serve as targets in diagnostic assays because they are associated with the viral particle and can be examined for immune recognition or detection. Assay results may help researchers investigate infection-related signals and compare antigenic properties across viruses. Their use connects structural virology with practical approaches for identifying or studying viral infection.
Antiviral studies can focus on nucleocapsid structure and the interactions that support genome packaging, assembly, release, or replication. Vaccine research can likewise consider nucleocapsid components as immune targets, particularly when evaluating antibody or T-cell responses. Understanding these properties may identify opportunities for therapeutic or vaccine development and clarify how viral structure relates to infection.